- Home
- DKNG vs DGX Comparison
DKNG vs DGX Comparison
Compare DKNG & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKNG
- DGX
- Stock Information
- Founded
- DKNG 2012
- DGX 1967
- Country
- DKNG United States
- DGX United States
- Employees
- DKNG N/A
- DGX N/A
- Industry
- DKNG Services-Misc. Amusement & Recreation
- DGX Medical Specialities
- Sector
- DKNG Consumer Discretionary
- DGX Health Care
- Exchange
- DKNG Nasdaq
- DGX Nasdaq
- Market Cap
- DKNG 20.6B
- DGX 17.5B
- IPO Year
- DKNG N/A
- DGX 1996
- Fundamental
- Price
- DKNG $39.84
- DGX $160.46
- Analyst Decision
- DKNG Strong Buy
- DGX Buy
- Analyst Count
- DKNG 27
- DGX 13
- Target Price
- DKNG $50.37
- DGX $163.38
- AVG Volume (30 Days)
- DKNG 10.3M
- DGX 1.0M
- Earning Date
- DKNG 11-07-2024
- DGX 10-22-2024
- Dividend Yield
- DKNG N/A
- DGX 1.87%
- EPS Growth
- DKNG N/A
- DGX 11.56
- EPS
- DKNG N/A
- DGX 7.44
- Revenue
- DKNG $4,605,784,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- DKNG $42.82
- DGX $7.33
- Revenue Next Year
- DKNG $22.41
- DGX $8.69
- P/E Ratio
- DKNG N/A
- DGX $21.57
- Revenue Growth
- DKNG 40.01
- DGX 2.60
- 52 Week Low
- DKNG $28.69
- DGX $123.04
- 52 Week High
- DKNG $49.57
- DGX $162.59
- Technical
- Relative Strength Index (RSI)
- DKNG 54.94
- DGX 60.76
- Support Level
- DKNG $38.10
- DGX $156.10
- Resistance Level
- DKNG $43.33
- DGX $162.59
- Average True Range (ATR)
- DKNG 1.46
- DGX 2.91
- MACD
- DKNG 0.43
- DGX 0.37
- Stochastic Oscillator
- DKNG 57.59
- DGX 79.72
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in 27 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.